Genmab A/S (GMAB)
31.33
-0.92
(-2.85%)
USD |
NASDAQ |
Jan 20, 16:00
31.33
0.00 (0.00%)
After-Hours: 20:00
Genmab Market Cap: 19.27B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 378.22B |
| Krystal Biotech, Inc. | 7.968B |
| Novo Nordisk A/S | 269.61B |
| Ascendis Pharma A/S | 13.14B |
| Evaxion AS | 29.56M |
Market Cap Related Metrics
| PE Ratio | 13.31 |
| PS Ratio | 5.485 |
| PEG Ratio | 0.1049 |
| Price to Book Value | 3.351 |
| Price to Free Cash Flow | 16.21 |
| Price | 31.33 |
| Earnings Yield | 7.51% |
| PEGY Ratio | 0.1049 |
| Operating PE Ratio | 14.89 |
| Normalized PE Ratio | 13.24 |